SHARE PURCHASE AGREEMENTShare Purchase Agreement • January 12th, 2022 • Xenon Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 12th, 2022 Company Industry JurisdictionThis Share Purchase Agreement (this “Agreement”), is made as of January 11, 2022 (the “Signing Date”), by and between Neurocrine Biosciences, Inc. (the “Investor”), a Delaware corporation, and Xenon Pharmaceuticals Inc. (the “Company”), a Canadian corporation.